Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

作者姓名：	Tak PP Mease PJ Genovese MC Kremer J Haraoui B Tanaka Y Bingham CO Ashrafzadeh A Travers H Safa-Leathers S Kumar S Dummer W

摘要：
本文献已被 PubMed 等数据库收录！